Fluoguide AS (FLUO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 4.485x

Based on the latest financial reports, Fluoguide AS (FLUO) has a cash flow conversion efficiency ratio of 4.485x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.97 Million ≈ $-1.18 Million USD) by net assets (Skr-2.44 Million ≈ $-263.12K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See FLUO equity financing ratio to measure how much of total assets are equity-financed.

Fluoguide AS - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Fluoguide AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Fluoguide AS (FLUO) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Fluoguide AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fluoguide AS ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Regis Corporation Common Stock
NYSE:RGS
0.009x
Sreeleathers Limited
NSE:SREEL
0.037x
Kedoya Adyaraya Tbk PT
JK:RSGK
-0.004x
Inspirato Inc
NASDAQ:ISPO
0.016x
Hil Industries Bhd
KLSE:8443
-0.027x
Sleep Cycle AB
ST:SLEEP
0.150x
Harmoney Corp Ltd
AU:HMY
0.514x
StoneBridge Ventures Inc.
KQ:330730
-0.023x

Annual Cash Flow Conversion Efficiency for Fluoguide AS (2018–2024)

The table below shows the annual cash flow conversion efficiency of Fluoguide AS from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see FLUO market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr23.07 Million
≈ $2.48 Million
Skr-29.15 Million
≈ $-3.14 Million
-1.264x +49.46%
2023-12-31 Skr12.72 Million
≈ $1.37 Million
Skr-31.81 Million
≈ $-3.42 Million
-2.501x -112.36%
2022-12-31 Skr31.97 Million
≈ $3.44 Million
Skr-37.65 Million
≈ $-4.05 Million
-1.178x -202.57%
2021-12-31 Skr38.70 Million
≈ $4.16 Million
Skr-15.06 Million
≈ $-1.62 Million
-0.389x +80.60%
2020-12-31 Skr4.41 Million
≈ $474.69K
Skr-8.85 Million
≈ $-952.08K
-2.006x +13.68%
2019-12-31 Skr4.54 Million
≈ $488.79K
Skr-10.55 Million
≈ $-1.14 Million
-2.323x -1390.74%
2018-12-31 Skr7.00K
≈ $753.31
Skr-1.09K
≈ $-117.41
-0.156x --

About Fluoguide AS

ST:FLUO Sweden Biotechnology
Market Cap
$54.19 Million
Skr503.56 Million SEK
Market Cap Rank
#21538 Global
#400 in Sweden
Share Price
Skr30.80
Change (1 day)
-2.22%
52-Week Range
Skr30.20 - Skr46.70
All Time High
Skr177.94
About

FluoGuide A/S, a clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. The company has a collaboration agreement with ZEISS Medical T… Read more